University of Virginia Cancer Center
1300 Jefferson Park Avenue
Charlottesville, VA 22908
The University of Virginia Cancer Center, located on the campus of the University of Virginia School of Medicine in Charlottesville, Virginia, is a National Cancer Institute-designated Cancer Center. The center’s approximately 160 researchers are drawn from 23 different academic departments. Research efforts are focused in five major areas: cancer cell signaling, chemical and structural biology, immunology/immunotherapy, molecular genetics and epigenetics, and women’s oncology. Clinical trials are coordinated by the Office for Clinical Research, which provides centralized support and data collection standards.
Patient care at the University of Virginia Cancer Center is provided for a dozen different broad cancer types. Available services include cancer prevention programs, screening, education and a range of therapies. Multidisciplinary Cancer Center Tumor Boards meet regularly to review cases, develop individual patient treatment plans and share research.
The University of Virginia was founded in 1819 by Thomas Jefferson, who was also the University’s chief architect and designer. The University opened in 1825 and graduated its first class in medical studies in 1828. The first University Hospital, with 25 beds, was completed in 1901, and the nursing program was established the same year. A new, 682-bed hospital opened in 1960, followed by the University of Virginia Replacement Hospital in 1989.
The University of Virginia Cancer Center was established during the tenure of Robert M. Carey, M.D., who served as Dean of the School of Medicine from 1986-2002. A recent capital campaign resulted in the construction of a new 150,000 square-foot outpatient cancer center, which opened in 2011. The Emily Couric Clinical Cancer Center is named for former Virginia State Senator Emily Couric, sister of news anchor Katie Couric. The center aims to provide patients with state-of-the-art treatment in a setting of dignity and comfort, using ample natural light and building materials.
Mesothelioma Treatment at University of Virginia Cancer Center
Malignant mesothelioma and other asbestos-related lung cancers are treated by the Thoracic Care Team at the University of Virginia Cancer Center. The team’s multidisciplinary approach allows clinicians and researchers to provide individualized care at every step. Early stage detection is possible in some cases with the use of a PET-CT scanner and new techniques for identifying tiny lesions on the lungs. Minimally invasive surgery and TomoTherapy, a targeted radiation therapy using 3-D imaging, are among the treatments available. In addition to diagnostic and treatment services, patients have access to a variety of support services, including educational resources, nutrition and spiritual counseling, and palliative care.
Patients may also benefit from participation in ongoing research and clinical trials. Patricia J. Hollen, PhD, RN, has been a primary researcher in a number of lung-cancer related studies, including a study of 495 mesothelioma patients which tracked the effects of symptoms experienced during treatment on the patients’ overall quality of life.
University of Virginia Cancer Center – general
University of Virginia School of Medicine – history
University of Virginia Cancer Center – Thoracic Care Team
University of Virginia Cancer Center – cancer researchers